DNA repair pathways as targets for cancer therapy - PubMed (original) (raw)
Review
doi: 10.1038/nrc2342.
Affiliations
- PMID: 18256616
- DOI: 10.1038/nrc2342
Review
DNA repair pathways as targets for cancer therapy
Thomas Helleday et al. Nat Rev Cancer. 2008 Mar.
Abstract
DNA repair pathways can enable tumour cells to survive DNA damage that is induced by chemotherapeutic treatments; therefore, inhibitors of specific DNA repair pathways might prove efficacious when used in combination with DNA-damaging chemotherapeutic drugs. In addition, alterations in DNA repair pathways that arise during tumour development can make some cancer cells reliant on a reduced set of DNA repair pathways for survival. There is evidence that drugs that inhibit one of these pathways in such tumours could prove useful as single-agent therapies, with the potential advantage that this approach could be selective for tumour cells and have fewer side effects.
Similar articles
- Cancer-specific defects in DNA repair pathways as targets for personalized therapeutic approaches.
Dietlein F, Thelen L, Reinhardt HC. Dietlein F, et al. Trends Genet. 2014 Aug;30(8):326-39. doi: 10.1016/j.tig.2014.06.003. Epub 2014 Jul 10. Trends Genet. 2014. PMID: 25017190 Review. - DNA damage detection and repair pathways--recent advances with inhibitors of checkpoint kinases in cancer therapy.
Ashwell S, Zabludoff S. Ashwell S, et al. Clin Cancer Res. 2008 Jul 1;14(13):4032-7. doi: 10.1158/1078-0432.CCR-07-5138. Clin Cancer Res. 2008. PMID: 18593978 Review. - Biomarkers to assess the targeting of DNA repair pathways to augment tumor response to therapy.
Nowsheen S, Whitley AC, Yang ES. Nowsheen S, et al. Curr Mol Med. 2012 Jul 1;12(6):788-803. doi: 10.2174/156652412800792615. Curr Mol Med. 2012. PMID: 22292444 Review. - DNA damage and repair in translational oncology: an overview.
Reed E. Reed E. Clin Cancer Res. 2010 Sep 15;16(18):4511-6. doi: 10.1158/1078-0432.CCR-10-0528. Epub 2010 Sep 7. Clin Cancer Res. 2010. PMID: 20823144 - Therapeutic potential of drugs to modulate DNA repair in cancer.
Curtin N. Curtin N. Expert Opin Ther Targets. 2007 Jun;11(6):783-99. doi: 10.1517/14728222.11.6.783. Expert Opin Ther Targets. 2007. PMID: 17504016 Review.
Cited by
- The synthesis of furoquinolinedione and isoxazoloquinolinedione derivatives as selective Tyrosyl-DNA phosphodiesterase 2 (TDP2) inhibitors.
Yang H, Zhu XQ, Wang W, Chen Y, Hu Z, Zhang Y, Hu DX, Yu LM, Agama K, Pommier Y, An LK. Yang H, et al. Bioorg Chem. 2021 Jun;111:104881. doi: 10.1016/j.bioorg.2021.104881. Epub 2021 Apr 1. Bioorg Chem. 2021. PMID: 33839584 Free PMC article. - Genome-wide adaptive evolution to underground stresses in subterranean mammals: Hypoxia adaption, immunity promotion, and sensory specialization.
Jiang M, Shi L, Li X, Dong Q, Sun H, Du Y, Zhang Y, Shao T, Cheng H, Chen W, Wang Z. Jiang M, et al. Ecol Evol. 2020 Jun 3;10(14):7377-7388. doi: 10.1002/ece3.6462. eCollection 2020 Jul. Ecol Evol. 2020. PMID: 32760535 Free PMC article. - Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Jacot W, Lusque A, Vicier C, Mailliez A, de La Motte Rouge T, Cabel L, Levy C, Patsouris A, Desmoulins I, Uwer L, Thery JC, Robain M, Caron O, Tredan O, Filleron T, Frenel JS, Delaloge S. Jacot W, et al. Br J Cancer. 2022 Nov;127(11):1963-1973. doi: 10.1038/s41416-022-02003-1. Epub 2022 Oct 7. Br J Cancer. 2022. PMID: 36207609 Free PMC article. Clinical Trial. - Study of local hydrodynamic environment in cell-substrate adhesion using side-view μPIV technology.
Fu Y, Kunz R, Wu J, Dong C. Fu Y, et al. PLoS One. 2012;7(2):e30721. doi: 10.1371/journal.pone.0030721. Epub 2012 Feb 17. PLoS One. 2012. PMID: 22363477 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources